DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

This publication has 15 references indexed in Scilit:

• Influenza vaccine: The challenge of antigenic drift
  Vaccine, 2007
• Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery
  Vaccine, 2007
• Design and Validation of an H5 TaqMan Real-Time One-Step Reverse Transcription-PCR and Confirmatory Assays for Diagnosis and Verification of Influenza A Virus H5 Infections in Humans
  Journal of Clinical Microbiology, 2007
• Vaccines for Seasonal and Pandemic Influenza
  The Journal of Infectious Diseases, 2006
• Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases
  Methods, 2006
• Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin
  Vaccine, 2006
• Epidermal DNA vaccine for influenza is immunogenic in humans
  Vaccine, 2006
• Rapid-response vaccines—does DNA offer a solution?
  Nature Biotechnology, 2005
• Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device
  Vaccine, 2005
• Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin fromEscherichia coliAre Strong Adjuvants for DNA Vaccines
  Journal of Virology, 2002